High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study

Etiology-specific onabotulinumtoxinA utilization to manage spasticity is largely unknown. In this 1-year interim analysis, we evaluated real-world onabotulinumtoxinA utilization and effectiveness across several etiologies from the Adult Spasticity International Registry (ASPIRE) study. ASPIRE is a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Francisco, Gerard E., Bandari, Daniel S., Bavikatte, Ganesh, Jost, Wolfgang H., McCusker, Emily, Largent, Joan, Zuzek, Aleksej, Esquenazi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article from Special Issue on Toxins 2019, Edited by:Dr. David Simpson, Dr. Marie Vidailhet, Dr. Matteo Caleo and Dr. Sabine Pellett
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452133/
https://www.ncbi.nlm.nih.gov/pubmed/32875289
http://dx.doi.org/10.1016/j.toxcx.2020.100040

Ejemplares similares

Ejemplares similares